TRIM21 and central nervous system cancer: According to the combined analysis of TCGA and GTEx data, TRIM21 is upregulated in a wide spectrum of cancers, such as glioma, melanoma, pancreatic adenocarcinoma and colorectum adenocarcinoma (Supplementary Figure S1).